Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
Price Target
Average
422.39%
Revenue Forecast
Estimate
--3.93%
EBIT
Estimate
58.25%
Net Income
Estimate
69.97%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Avalo Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for AVTX of $35 , with forecasts ranging from
a
low of
$35 to a high of $35 .
AVTX Lowest Price Target
Wall Street Target
35 USD
422.39%
AVTX Average Price Target
Wall Street Target
35 USD
422.39%
AVTX Highest Price Target
Wall Street Target
35 USD
422.39%
REVENUE FORECAST
Revenue Forecast Chart AVTX
EBIT FORECAST
EBIT Forecast Chart AVTX
NET INCOME FORECAST
Net Income Chart AVTX